Liabilities / Assets
51st percentile
Higher debt load relative to assets than 51% of similar nonprofits.
990 • Fiscal year 2021 • EIN 85-1457272
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
51st percentile
Higher debt load relative to assets than 51% of similar nonprofits.
Liabilities / Revenue
30th percentile
Higher debt load relative to revenue than 30% of similar nonprofits.
Net Margin
53rd percentile
Higher net margin than 53% of similar nonprofits.
Top Officer Pay
78th percentile
Higher top officer pay than 78% of similar nonprofits.
Top officer pay equals 4.5% of source-year revenue.
Asset Growth
96th percentile
Faster asset growth than 96% of similar nonprofits.
Revenue Growth
97th percentile
Faster revenue growth than 97% of similar nonprofits.
Assets
Up$708,627
Up $446,655 (+170%) from 2020
Net Assets
Up$656,136
Up $406,164 (+162%) from 2020
Liabilities
Up$52,491
Up $40,491 (+337%) from 2020
Revenue
Up$2,774,349
Up $2,240,895 (+420%) from 2020
Expenses
Up$2,373,123
Up $2,088,591 (+734%) from 2020
Net Income
Up$401,226
Up $152,304 (+61%) from 2020
The clock foundation was formed for the specific and primary purpose of conducting medical research on aging and age-related diseases. Developing the epigenetic aging clock into a useful technology will require medical research on aging and age-related diseases. Consequently, the activity will advance clock foundation's specific purpose of conducting medical research on aging and age-related diseases. If the medical research of the clock foundation is successful and the fda approves the clock foundation's testing method, many new drugs or treatments that are able to reverse epigenetic aging could then be formally approved by the fda for the treatment of aging and for use in preventative medicine.
The epigenetic clock development foundation ("clock foundation") was formed to enable rigorous medical research on aging and longevity. Our research mainly involves use and development of new aging biomarkers known as epigenetic clocks for testing the effectiveness of longevity treatments within preclinical and clinical studies.
| Line | Beginning | End | Change |
|---|---|---|---|
| Assets | |||
| Savings and Temporary Cash Investments | $250,371 | $430,291 | ▲ $179,920 |
| Accounts Receivable | $11,040 | $247,180 | ▲ $236,140 |
| Prepaid Expenses and Deferred Charges | $561 | $11,937 | ▲ $11,376 |
| Total Assets | $261,972 | $708,627 | ▲ $446,655 |
| Other Assets Total | - | $19,219 | - |
| Liabilities | |||
| Accounts Payable and Accrued Expenses | $11,998 | $52,230 | ▲ $40,232 |
| Other Liabilities | - | $261 | - |
| Total Liabilities | $11,998 | $52,491 | ▲ $40,493 |
| Net Assets / Fund Balance | |||
| Net Assets Without Donor Restrictions | $249,974 | $656,136 | ▲ $406,162 |
| Total Net Assets Fund Balance | $249,974 | $656,136 | ▲ $406,162 |
| Total Liabilities and Net Assets / Fund Balance | $261,972 | $708,627 | ▲ $446,655 |
| Name | Title | Full / Part Time | Base | Total |
|---|---|---|---|---|
| Stefan Horvath | Director, Ch | - | $123,958 | $123,958 |
| Robert Brooke | Executive Di | PT | $120,000 | $120,000 |
| Name | Title |
|---|---|
| Dean Prissman | Director |
| Line Item | Amount |
|---|---|
| Other Expenses | $1,960,660 |
| Salaries, Compensation, and Employee Benefits | $412,463 |
| Grants and Similar Amounts Paid | $0 |
| Professional Fundraising Fees | $0 |
| Total Fundraising Expense | $0 |
| Line Item | Program | Management | Fundraising | Total |
|---|---|---|---|---|
| Fees for Services Other | $330,477 | - | - | $330,477 |
| Current Officers, Directors, Trustees, and Key Employees | $123,958 | $120,000 | - | $243,958 |
| Other Salaries and Wages | $138,960 | - | - | $138,960 |
| Insurance | $57,588 | - | - | $57,588 |
| Occupancy | $36,660 | - | - | $36,660 |
| Payroll Taxes | $29,545 | - | - | $29,545 |
| Other Expenses | $24,549 | - | - | $24,549 |
| All Other Expenses | $17,820 | - | - | $17,820 |
| Fees for Services Accounting | $11,576 | - | - | $11,576 |
| Fees for Services Legal | $11,045 | - | - | $11,045 |
| Advertising | $4,726 | - | - | $4,726 |
| Office Expenses | $3,619 | - | - | $3,619 |
| Travel | $2,625 | - | - | $2,625 |
| Total Functional Expenses | $2,253,123 | $120,000 | $0 | $2,373,123 |
| Line Item | Amount |
|---|---|
| Professional Fundraising Fees | $0 |
| Liability | Amount |
|---|---|
| CA Pit / Sdi | $261 |
“Financials are prepared by a bookkeeper with input from a certified public accountant. Tax accountants prepare the filing. Executive director reviews and receives input from legal counsel prior to filing.”
“Officers, directors, employees and volunteers of epigenetic clock development foundation are encouraged to bring any alleged unlawful activity, policy or practice to the attenion of epigenetic clock development foundation. A protest, concern or complaint shall be made in writing to the president of epigenetic clock development foundation.”
“Board members and donor organizations are made aware of and able to review executive and key employee compensation through independent reports and through approval of annual budgets.”
“Board members and donor organizations are made aware of and able to review executive and key employee compensation through independent reports and through approval of annual budgets.”
“The documents are made available upon request.”
“The clock foundation was formed for the specific and primary purpose of conducting medical research on aging and age-related diseases. Developing the epigenetic aging clock into a useful technology will require medical research on aging and age-related diseases. Consequently, the activity will advance clock foundation's specific purpose of conducting medical research on aging and age-related diseases. If the medical research of the clock foundation is successful and the fda approves the clock foundation's testing method, many new drugs or treatments that are able to reverse epigenetic aging could then be formally approved by the fda for the treatment of aging and for use in preventative medicine.”
“Internal research program: hiring of additional clock foundation team members we hired an additional phd biostatistician, along with additional part-time operational, administration, and finance staff. We continued to work closely with our scientific advisory board, especially on the development of rigorous approaches for epigenetic clock testing. Exclusive ucla ip license completed an exclusive license to the horvath ip portfolio was obtained in june 2021. No additional sublicenses or outlicensing agreements have been entered into, although we entered into several research collaboration agreements with groups this year.”
“External research collaborations: many interventional studies completed one of the most significant promises of epigenetic clocks is to act as a reliable biomarker to evaluate putative longevity treatments. We conducted many new interventional studies, for clinical trials and also preclinical studies, some with exciting effects and others with mediocre or negative results. This includes studies on plasmapharesis, young plasma treatment, stem cell exosomes, umbilical cord plasma, and a senolytic gene therapy. Mechanisms of aging studies ongoing another key application of epigenetic clocks is to help enable mechanistic studies, including the link of epigenetic aging to other aging hallmarks. Exciting mechanistic studies this past year included ones on ercc1 progeria models, bone marrow transplants, and progeria cell lines.”
“OTHER PROGRAM SERVICES”
“Intl property 142,706 0 0 advisory fee 93,604 0 0 advisory fee - vugene llc 94,167 0 0 total 330,477 0 0”
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990/AccountantCompileOrReviewInd | 0 | false |
| IRS990/AccountsPayableAccrExpnssGrp/BOYAmt | 0 | 11998 |
| IRS990/AccountsPayableAccrExpnssGrp/EOYAmt | 0 | 52230 |
| IRS990/AccountsReceivableGrp/BOYAmt | 0 | 11040 |
| IRS990/AccountsReceivableGrp/EOYAmt | 0 | 247180 |
| IRS990/ActivitiesConductedPrtshpInd | 0 | false |
| IRS990/ActivityOrMissionDesc | 0 | THE EPIGENETIC CLOCK DEVELOPMENT FOUNDATION ("CLOCK FOUNDATION") WAS FORMED TO ENABLE RIGOROUS MEDICAL RESEARCH ON AGING AND LONGEVITY. OUR RESEARCH MAINLY INVOLVES USE AND DEVELOPMENT OF NEW AGING BIOMARKERS KNOWN AS EPIGENETIC CLOCKS FOR TESTING THE EFFECTIVENESS OF LONGEVITY TREATMENTS WITHIN PRECLINICAL AND CLINICAL STUDIES. |
| IRS990/AdvertisingGrp/ProgramServicesAmt | 0 | 4726 |
| IRS990/AdvertisingGrp/TotalAmt | 0 | 4726 |
| IRS990/AllOtherContributionsAmt | 0 | 1500000 |
| IRS990/AllOtherExpensesGrp/ProgramServicesAmt | 0 | 17820 |
| IRS990/AllOtherExpensesGrp/TotalAmt | 0 | 17820 |
| IRS990/AnnualDisclosureCoveredPrsnInd | 0 | true |
| IRS990/ApplicationPendingInd | 0 | X |
| IRS990/BackupWthldComplianceInd | 0 | false |
| IRS990/BooksInCareOfDetail/PersonNm | 0 | ROBERT BROOKE |
| IRS990/BooksInCareOfDetail/PhoneNum | 0 | 5138699793 |
| IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 1124 W CARSON ST BLDG 3RD |
| IRS990/BooksInCareOfDetail/USAddress/CityNm | 0 | TORRANCE |
| IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | CA |
| IRS990/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 90502 |
| IRS990/BusinessRlnWith35CtrlEntInd | 0 | false |
| IRS990/BusinessRlnWithFamMemInd | 0 | false |
| IRS990/BusinessRlnWithOrgMemInd | 0 | false |
| IRS990/ChangeToOrgDocumentsInd | 0 | false |
| IRS990/CollectionsOfArtInd | 0 | false |
| IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt | 0 | 120000 |
| IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt | 0 | 123958 |
| IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt | 0 | 243958 |
| IRS990/CompensationFromOtherSrcsInd | 0 | false |
| IRS990/CompensationProcessCEOInd | 0 | true |
| IRS990/CompensationProcessOtherInd | 0 | true |
| IRS990/ConflictOfInterestPolicyInd | 0 | true |
| IRS990/ConservationEasementsInd | 0 | false |
| IRS990/ConsolidatedAuditFinclStmtInd | 0 | false |
| IRS990/CreditCounselingInd | 0 | false |
| IRS990/CYBenefitsPaidToMembersAmt | 0 | 0 |
| IRS990/CYContributionsGrantsAmt | 0 | 1500000 |
| IRS990/CYGrantsAndSimilarPaidAmt | 0 | 0 |
| IRS990/CYInvestmentIncomeAmt | 0 | 45 |
| IRS990/CYOtherExpensesAmt | 0 | 1960660 |
| IRS990/CYOtherRevenueAmt | 0 | 427243 |
| IRS990/CYProgramServiceRevenueAmt | 0 | 847061 |
| IRS990/CYRevenuesLessExpensesAmt | 0 | 401226 |
| IRS990/CYSalariesCompEmpBnftPaidAmt | 0 | 412463 |
| IRS990/CYTotalExpensesAmt | 0 | 2373123 |
| IRS990/CYTotalFundraisingExpenseAmt | 0 | 0 |
| IRS990/CYTotalProfFndrsngExpnsAmt | 0 | 0 |
| IRS990/CYTotalRevenueAmt | 0 | 2774349 |
| IRS990/DecisionsSubjectToApprovaInd | 0 | false |
| IRS990/DeductibleArtContributionInd | 0 | false |
| IRS990/DeductibleNonCashContriInd | 0 | false |
| IRS990/DelegationOfMgmtDutiesInd | 0 | false |
| IRS990/Desc | 0 | INTERNAL RESEARCH PROGRAM: HIRING OF ADDITIONAL CLOCK FOUNDATION TEAM MEMBERS WE HIRED AN ADDITIONAL PHD BIOSTATISTICIAN, ALONG WITH ADDITIONAL PART-TIME OPERATIONAL, ADMINISTRATION, AND FINANCE STAFF. WE CONTINUED TO WORK CLOSELY WITH OUR SCIENTIFIC ADVISORY BOARD, ESPECIALLY ON THE DEVELOPMENT OF RIGOROUS APPROACHES FOR EPIGENETIC CLOCK TESTING. EXCLUSIVE UCLA IP LICENSE COMPLETED AN EXCLUSIVE LICENSE TO THE HORVATH IP PORTFOLIO WAS OBTAINED IN JUNE 2021. NO ADDITIONAL SUBLICENSES OR OUTLICENSING AGREEMENTS HAVE BEEN ENTERED INTO, ALTHOUGH WE ENTERED INTO SEVERAL RESEARCH COLLABORATION AGREEMENTS WITH GROUPS THIS YEAR. |
| IRS990/DescribedInSection501c3Ind | 0 | true |
| IRS990/DisregardedEntityInd | 0 | false |
| IRS990/DocumentRetentionPolicyInd | 0 | true |
| IRS990/DonorAdvisedFundInd | 0 | false |
| IRS990/DonorRstrOrQuasiEndowmentsInd | 0 | false |
| IRS990/ElectionOfBoardMembersInd | 0 | false |
| IRS990/EmployeeCnt | 0 | 6 |
| IRS990/EmploymentTaxReturnsFiledInd | 0 | true |
| IRS990/EngagedInExcessBenefitTransInd | 0 | false |
| IRS990/ExpenseAmt | 0 | 114894 |
| IRS990/FamilyOrBusinessRlnInd | 0 | false |
| IRS990/FeesForServicesAccountingGrp/ProgramServicesAmt | 0 | 11576 |
| IRS990/FeesForServicesAccountingGrp/TotalAmt | 0 | 11576 |
| IRS990/FeesForServicesLegalGrp/ProgramServicesAmt | 0 | 11045 |
| IRS990/FeesForServicesLegalGrp/TotalAmt | 0 | 11045 |
| IRS990/FeesForServicesOtherGrp/ProgramServicesAmt | 0 | 330477 |
| IRS990/FeesForServicesOtherGrp/TotalAmt | 0 | 330477 |
| IRS990/ForeignActivitiesInd | 0 | false |
| IRS990/ForeignFinancialAccountInd | 0 | false |
| IRS990/ForeignOfficeInd | 0 | false |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 0 | 4.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 1 | 30.00 |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 0 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 1 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 2 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 0 | X |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 0 | STEFAN HORVATH |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 1 | ROBERT BROOKE |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 2 | DEAN PRISSMAN |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 0 | 123958 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 1 | 120000 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 0 | DIRECTOR, CH |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 1 | EXECUTIVE DI |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 2 | DIRECTOR |
| IRS990/Form990ProvidedToGvrnBodyInd | 0 | false |
| IRS990/FormationYr | 0 | 2020 |
| IRS990/FormerOfcrEmployeesListedInd | 0 | false |
| IRS990/FSAuditedInd | 0 | false |
| IRS990/FundraisingActivitiesInd | 0 | false |
| IRS990/GamingActivitiesInd | 0 | false |
| IRS990/GoverningBodyVotingMembersCnt | 0 | 3 |
| IRS990/GrantsToIndividualsInd | 0 | false |
| IRS990/GrantsToOrganizationsInd | 0 | false |
| IRS990/GrantToRelatedPersonInd | 0 | false |
| IRS990/GrossReceiptsAmt | 0 | 2774349 |
| IRS990/GroupReturnForAffiliatesInd | 0 | false |
| IRS990/IncludeFIN48FootnoteInd | 0 | false |
| IRS990/IndependentAuditFinclStmtInd | 0 | false |
| IRS990/IndependentVotingMemberCnt | 0 | 3 |
| IRS990/IndivRcvdGreaterThan100KCnt | 0 | 2 |
| IRS990/IndoorTanningServicesInd | 0 | false |
| IRS990/InfoInScheduleOPartIIIInd | 0 | X |
| IRS990/InfoInScheduleOPartIXInd | 0 | X |
| IRS990/InfoInScheduleOPartVIInd | 0 | X |
| IRS990/InsuranceGrp/ProgramServicesAmt | 0 | 57588 |
| IRS990/InsuranceGrp/TotalAmt | 0 | 57588 |
| IRS990/InvestmentIncomeGrp/RelatedOrExemptFuncIncomeAmt | 0 | 45 |
| IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt | 0 | 45 |
| IRS990/InvestmentInJointVentureInd | 0 | false |
| IRS990/IRPDocumentCnt | 0 | 5 |
| IRS990/IRPDocumentW2GCnt | 0 | 0 |
| IRS990/LegalDomicileStateCd | 0 | CA |
| IRS990/LoanOutstandingInd | 0 | false |
| IRS990/LobbyingActivitiesInd | 0 | false |
| IRS990/LocalChaptersInd | 0 | false |
| IRS990/MaterialDiversionOrMisuseInd | 0 | false |
| IRS990/MembersOrStockholdersInd | 0 | false |
| IRS990/MethodOfAccountingAccrualInd | 0 | X |
| IRS990/MinutesOfCommitteesInd | 0 | true |
| IRS990/MinutesOfGoverningBodyInd | 0 | true |
| IRS990/MissionDesc | 0 | THE CLOCK FOUNDATION WAS FORMED FOR THE SPECIFIC AND PRIMARY PURPOSE OF CONDUCTING MEDICAL RESEARCH ON AGING AND AGE-RELATED DISEASES. DEVELOPING THE EPIGENETIC AGING CLOCK INTO A USEFUL TECHNOLOGY WILL REQUIRE MEDICAL RESEARCH ON AGING AND AGE-RELATED DISEASES. CONSEQUENTLY, THE ACTIVITY WILL ADVANCE CLOCK FOUNDATION'S SPECIFIC PURPOSE OF CONDUCTING MEDICAL RESEARCH ON AGING AND AGE-RELATED DISEASES. IF THE MEDICAL RESEARCH OF THE CLOCK FOUNDATION IS SUCCESSFUL AND THE FDA APPROVES THE CLOCK FOUNDATION'S TESTING METHOD, MANY NEW DRUGS OR TREATMENTS THAT ARE ABLE TO REVERSE EPIGENETIC AGING COULD THEN BE FORMALLY APPROVED BY THE FDA FOR THE TREATMENT OF AGING AND FOR USE IN PREVENTATIVE MEDICINE. |
| IRS990/MoreThan5000KToIndividualsInd | 0 | false |
| IRS990/MoreThan5000KToOrgInd | 0 | false |
| IRS990/NetAssetsOrFundBalancesBOYAmt | 0 | 249974 |
| IRS990/NetAssetsOrFundBalancesEOYAmt | 0 | 656136 |
| IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt | 0 | 249974 |
| IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt | 0 | 656136 |
| IRS990/NondeductibleContributionsInd | 0 | false |
| IRS990/OccupancyGrp/ProgramServicesAmt | 0 | 36660 |
| IRS990/OccupancyGrp/TotalAmt | 0 | 36660 |
| IRS990/OfficeExpensesGrp/ProgramServicesAmt | 0 | 3619 |
| IRS990/OfficeExpensesGrp/TotalAmt | 0 | 3619 |
| IRS990/OfficerMailingAddressInd | 0 | false |
| IRS990/OperateHospitalInd | 0 | false |
| IRS990/Organization501c3Ind | 0 | X |
| IRS990/OrganizationFollowsFASB117Ind | 0 | X |
| IRS990/OtherAssetsTotalGrp/EOYAmt | 0 | 19219 |
| IRS990/OtherExpensesGrp/Desc | 0 | SPONSORED EPIGENETIC TEST |
| IRS990/OtherExpensesGrp/Desc | 1 | TREATMENT TESTING SERVICE |
| IRS990/OtherExpensesGrp/Desc | 2 | SUPPLIES |
| IRS990/OtherExpensesGrp/Desc | 3 | RESEARCH AND DEVELOPMENT |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 0 | 1350427 |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 1 | 82627 |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 2 | 26921 |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 3 | 24549 |
| IRS990/OtherExpensesGrp/TotalAmt | 0 | 1350427 |
| IRS990/OtherExpensesGrp/TotalAmt | 1 | 82627 |
| IRS990/OtherExpensesGrp/TotalAmt | 2 | 26921 |
| IRS990/OtherExpensesGrp/TotalAmt | 3 | 24549 |
| IRS990/OtherLiabilitiesGrp/EOYAmt | 0 | 261 |
| IRS990/OtherRevenueMiscGrp/Desc | 0 | SALES |
| IRS990/OtherRevenueMiscGrp/Desc | 1 | CONTRACT INCOME |
| IRS990/OtherRevenueMiscGrp/RelatedOrExemptFuncIncomeAmt | 0 | 416843 |
| IRS990/OtherRevenueMiscGrp/RelatedOrExemptFuncIncomeAmt | 1 | 10400 |
| IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt | 0 | 416843 |
| IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt | 1 | 10400 |
| IRS990/OtherRevenueTotalAmt | 0 | 427243 |
| IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt | 0 | 138960 |
| IRS990/OtherSalariesAndWagesGrp/TotalAmt | 0 | 138960 |
| IRS990/OwnWebsiteInd | 0 | X |
| IRS990/PartialLiquidationInd | 0 | false |
| IRS990/PayrollTaxesGrp/ProgramServicesAmt | 0 | 29545 |
| IRS990/PayrollTaxesGrp/TotalAmt | 0 | 29545 |
| IRS990/PoliticalCampaignActyInd | 0 | false |
| IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt | 0 | 561 |
| IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt | 0 | 11937 |
| IRS990/PrincipalOfficerNm | 0 | ROBERT BROOKE |
| IRS990/PriorPeriodAdjustmentsAmt | 0 | 4936 |
| IRS990/ProfessionalFundraisingInd | 0 | false |
| IRS990/ProgramServiceRevenueGrp/Desc | 0 | FEE FOR SERVICE INCOME |
| IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt | 0 | 847061 |
| IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt | 0 | 847061 |
| IRS990/ProgSrvcAccomActy2Grp/Desc | 0 | EXTERNAL RESEARCH COLLABORATIONS: MANY INTERVENTIONAL STUDIES COMPLETED ONE OF THE MOST SIGNIFICANT PROMISES OF EPIGENETIC CLOCKS IS TO ACT AS A RELIABLE BIOMARKER TO EVALUATE PUTATIVE LONGEVITY TREATMENTS. WE CONDUCTED MANY NEW INTERVENTIONAL STUDIES, FOR CLINICAL TRIALS AND ALSO PRECLINICAL STUDIES, SOME WITH EXCITING EFFECTS AND OTHERS WITH MEDIOCRE OR NEGATIVE RESULTS. THIS INCLUDES STUDIES ON PLASMAPHARESIS, YOUNG PLASMA TREATMENT, STEM CELL EXOSOMES, UMBILICAL CORD PLASMA, AND A SENOLYTIC GENE THERAPY. MECHANISMS OF AGING STUDIES ONGOING ANOTHER KEY APPLICATION OF EPIGENETIC CLOCKS IS TO HELP ENABLE MECHANISTIC STUDIES, INCLUDING THE LINK OF EPIGENETIC AGING TO OTHER AGING HALLMARKS. EXCITING MECHANISTIC STUDIES THIS PAST YEAR INCLUDED ONES ON ERCC1 PROGERIA MODELS, BONE MARROW TRANSPLANTS, AND PROGERIA CELL LINES. |
| IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt | 0 | 1669189 |
| IRS990/ProgSrvcAccomActy2Grp/RevenueAmt | 0 | 847061 |
| IRS990/ProgSrvcAccomActyOtherGrp/Desc | 0 | OTHER PROGRAM SERVICES |
| IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt | 0 | 469040 |
| IRS990/ProhibitedTaxShelterTransInd | 0 | false |
| IRS990/PYContributionsGrantsAmt | 0 | 500000 |
| IRS990/PYExcessBenefitTransInd | 0 | false |
| IRS990/PYInvestmentIncomeAmt | 0 | 14 |
| IRS990/PYOtherExpensesAmt | 0 | 199530 |
| IRS990/PYProgramServiceRevenueAmt | 0 | 33440 |
| IRS990/PYRevenuesLessExpensesAmt | 0 | 248924 |
| IRS990/PYSalariesCompEmpBnftPaidAmt | 0 | 85000 |
| IRS990/PYTotalExpensesAmt | 0 | 284530 |
| IRS990/PYTotalRevenueAmt | 0 | 533454 |
| IRS990/ReconcilationRevenueExpnssAmt | 0 | 401226 |
| IRS990/RegularMonitoringEnfrcInd | 0 | true |
| IRS990/RelatedEntityInd | 0 | false |
| IRS990/RelatedOrganizationCtrlEntInd | 0 | false |
| IRS990/ReportInvestmentsOtherSecInd | 0 | false |
| IRS990/ReportLandBuildingEquipmentInd | 0 | false |
| IRS990/ReportOtherAssetsInd | 0 | false |
| IRS990/ReportOtherLiabilitiesInd | 0 | true |
| IRS990/ReportProgramRelatedInvstInd | 0 | false |
| IRS990/SavingsAndTempCashInvstGrp/BOYAmt | 0 | 250371 |
| IRS990/SavingsAndTempCashInvstGrp/EOYAmt | 0 | 430291 |
| IRS990ScheduleA/HospitalNameAndAddressGrp/CityNm | 0 | TORRANCE |
| IRS990ScheduleA/HospitalNameAndAddressGrp/StateAbbreviationCd | 0 | CA |
| IRS990ScheduleA/HospitalNameAndAddressGrp/SupportedOrganizationName/BusinessNameLine1Txt | 0 | HARBOR UCLA MEDICAL CENTER |
| IRS990ScheduleA/MedicalResearchOrganizationInd | 0 | X |
| IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorNum | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine2 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt | 0 | RESTRICTED |
| IRS990/ScheduleBRequiredInd | 0 | true |
| IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt | 0 | 261 |
| IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc | 0 | CA PIT / SDI |
| IRS990ScheduleD/TotalLiabilityAmt | 0 | 261 |
| IRS990/ScheduleJRequiredInd | 0 | false |
| IRS990/ScheduleORequiredInd | 0 | true |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 0 | THE CLOCK FOUNDATION WAS FORMED FOR THE SPECIFIC AND PRIMARY PURPOSE OF CONDUCTING MEDICAL RESEARCH ON AGING AND AGE-RELATED DISEASES. DEVELOPING THE EPIGENETIC AGING CLOCK INTO A USEFUL TECHNOLOGY WILL REQUIRE MEDICAL RESEARCH ON AGING AND AGE-RELATED DISEASES. CONSEQUENTLY, THE ACTIVITY WILL ADVANCE CLOCK FOUNDATION'S SPECIFIC PURPOSE OF CONDUCTING MEDICAL RESEARCH ON AGING AND AGE-RELATED DISEASES. IF THE MEDICAL RESEARCH OF THE CLOCK FOUNDATION IS SUCCESSFUL AND THE FDA APPROVES THE CLOCK FOUNDATION'S TESTING METHOD, MANY NEW DRUGS OR TREATMENTS THAT ARE ABLE TO REVERSE EPIGENETIC AGING COULD THEN BE FORMALLY APPROVED BY THE FDA FOR THE TREATMENT OF AGING AND FOR USE IN PREVENTATIVE MEDICINE. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 1 | INTERNAL RESEARCH PROGRAM: HIRING OF ADDITIONAL CLOCK FOUNDATION TEAM MEMBERS WE HIRED AN ADDITIONAL PHD BIOSTATISTICIAN, ALONG WITH ADDITIONAL PART-TIME OPERATIONAL, ADMINISTRATION, AND FINANCE STAFF. WE CONTINUED TO WORK CLOSELY WITH OUR SCIENTIFIC ADVISORY BOARD, ESPECIALLY ON THE DEVELOPMENT OF RIGOROUS APPROACHES FOR EPIGENETIC CLOCK TESTING. EXCLUSIVE UCLA IP LICENSE COMPLETED AN EXCLUSIVE LICENSE TO THE HORVATH IP PORTFOLIO WAS OBTAINED IN JUNE 2021. NO ADDITIONAL SUBLICENSES OR OUTLICENSING AGREEMENTS HAVE BEEN ENTERED INTO, ALTHOUGH WE ENTERED INTO SEVERAL RESEARCH COLLABORATION AGREEMENTS WITH GROUPS THIS YEAR. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 2 | EXTERNAL RESEARCH COLLABORATIONS: MANY INTERVENTIONAL STUDIES COMPLETED ONE OF THE MOST SIGNIFICANT PROMISES OF EPIGENETIC CLOCKS IS TO ACT AS A RELIABLE BIOMARKER TO EVALUATE PUTATIVE LONGEVITY TREATMENTS. WE CONDUCTED MANY NEW INTERVENTIONAL STUDIES, FOR CLINICAL TRIALS AND ALSO PRECLINICAL STUDIES, SOME WITH EXCITING EFFECTS AND OTHERS WITH MEDIOCRE OR NEGATIVE RESULTS. THIS INCLUDES STUDIES ON PLASMAPHARESIS, YOUNG PLASMA TREATMENT, STEM CELL EXOSOMES, UMBILICAL CORD PLASMA, AND A SENOLYTIC GENE THERAPY. MECHANISMS OF AGING STUDIES ONGOING ANOTHER KEY APPLICATION OF EPIGENETIC CLOCKS IS TO HELP ENABLE MECHANISTIC STUDIES, INCLUDING THE LINK OF EPIGENETIC AGING TO OTHER AGING HALLMARKS. EXCITING MECHANISTIC STUDIES THIS PAST YEAR INCLUDED ONES ON ERCC1 PROGERIA MODELS, BONE MARROW TRANSPLANTS, AND PROGERIA CELL LINES. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 3 | OTHER PROGRAM SERVICES |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 4 | FINANCIALS ARE PREPARED BY A BOOKKEEPER WITH INPUT FROM A CERTIFIED PUBLIC ACCOUNTANT. TAX ACCOUNTANTS PREPARE THE FILING. EXECUTIVE DIRECTOR REVIEWS AND RECEIVES INPUT FROM LEGAL COUNSEL PRIOR TO FILING. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 5 | OFFICERS, DIRECTORS, EMPLOYEES AND VOLUNTEERS OF EPIGENETIC CLOCK DEVELOPMENT FOUNDATION ARE ENCOURAGED TO BRING ANY ALLEGED UNLAWFUL ACTIVITY, POLICY OR PRACTICE TO THE ATTENION OF EPIGENETIC CLOCK DEVELOPMENT FOUNDATION. A PROTEST, CONCERN OR COMPLAINT SHALL BE MADE IN WRITING TO THE PRESIDENT OF EPIGENETIC CLOCK DEVELOPMENT FOUNDATION. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 6 | BOARD MEMBERS AND DONOR ORGANIZATIONS ARE MADE AWARE OF AND ABLE TO REVIEW EXECUTIVE AND KEY EMPLOYEE COMPENSATION THROUGH INDEPENDENT REPORTS AND THROUGH APPROVAL OF ANNUAL BUDGETS. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 7 | BOARD MEMBERS AND DONOR ORGANIZATIONS ARE MADE AWARE OF AND ABLE TO REVIEW EXECUTIVE AND KEY EMPLOYEE COMPENSATION THROUGH INDEPENDENT REPORTS AND THROUGH APPROVAL OF ANNUAL BUDGETS. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 8 | THE DOCUMENTS ARE MADE AVAILABLE UPON REQUEST. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 9 | INTL PROPERTY 142,706 0 0 ADVISORY FEE 93,604 0 0 ADVISORY FEE - VUGENE LLC 94,167 0 0 TOTAL 330,477 0 0 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | FORM 990 - ORGANIZATION'S MISSION |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 1 | FORM 990, PAGE 2, PART III, LINE 4A |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 2 | FORM 990, PAGE 2, PART III, LINE 4B |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 3 | FORM 990, PAGE 2, PART III, LINE 4D |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 4 | FORM 990, PAGE 6, PART VI, LINE 11B |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 5 | FORM 990, PAGE 6, PART VI, LINE 12C |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 6 | FORM 990, PAGE 6, PART VI, LINE 15A |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 7 | FORM 990, PAGE 6, PART VI, LINE 15B |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 8 | FORM 990, PAGE 6, PART VI, LINE 19 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 9 | FORM 990, PART IX, LINE 11G |
| IRS990/SchoolOperatingInd | 0 | false |
| IRS990/SignificantChangeInd | 0 | false |
| IRS990/SignificantNewProgramSrvcInd | 0 | false |
| IRS990/StatesWhereCopyOfReturnIsFldCd | 0 | CA |
| IRS990/SubjectToExcsTaxNetInvstIncInd | 0 | false |
| IRS990/SubjectToProxyTaxInd | 0 | false |
| IRS990/SubjToTaxRmnrtnExPrchtPymtInd | 0 | false |
| IRS990/TaxablePartyNotificationInd | 0 | false |
| IRS990/TaxExemptBondsInd | 0 | false |
| IRS990/TerminateOperationsInd | 0 | false |
| IRS990/TotalAssetsBOYAmt | 0 | 261972 |
| IRS990/TotalAssetsEOYAmt | 0 | 708627 |
| IRS990/TotalAssetsGrp/BOYAmt | 0 | 261972 |
| IRS990/TotalAssetsGrp/EOYAmt | 0 | 708627 |
| IRS990/TotalCompGreaterThan150KInd | 0 | false |
| IRS990/TotalContributionsAmt | 0 | 1500000 |
| IRS990/TotalEmployeeCnt | 0 | 6 |
| IRS990/TotalFunctionalExpensesGrp/FundraisingAmt | 0 | 0 |
| IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt | 0 | 120000 |
| IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt | 0 | 2253123 |
| IRS990/TotalFunctionalExpensesGrp/TotalAmt | 0 | 2373123 |
| IRS990/TotalGrossUBIAmt | 0 | 0 |
| IRS990/TotalLiabilitiesBOYAmt | 0 | 11998 |
| IRS990/TotalLiabilitiesEOYAmt | 0 | 52491 |
| IRS990/TotalLiabilitiesGrp/BOYAmt | 0 | 11998 |
| IRS990/TotalLiabilitiesGrp/EOYAmt | 0 | 52491 |
| IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt | 0 | 249974 |
| IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt | 0 | 656136 |
| IRS990/TotalOtherProgSrvcExpenseAmt | 0 | 469040 |
| IRS990/TotalProgramServiceExpensesAmt | 0 | 2253123 |
| IRS990/TotalProgramServiceRevenueAmt | 0 | 847061 |
| IRS990/TotalReportableCompFromOrgAmt | 0 | 243958 |
| IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt | 0 | 1274349 |
| IRS990/TotalRevenueGrp/TotalRevenueColumnAmt | 0 | 2774349 |
| IRS990/TotalVolunteersCnt | 0 | 2 |
| IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt | 0 | 261972 |
| IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt | 0 | 708627 |
| IRS990/TravelGrp/ProgramServicesAmt | 0 | 2625 |
| IRS990/TravelGrp/TotalAmt | 0 | 2625 |
| IRS990/TrnsfrExmptNonChrtblRltdOrgInd | 0 | false |
| IRS990/TypeOfOrganizationCorpInd | 0 | X |
| IRS990/UnrelatedBusIncmOverLimitInd | 0 | false |
| IRS990/UponRequestInd | 0 | X |
| IRS990/USAddress/AddressLine1Txt | 0 | 1124 W CARSON ST MRL BLDG 3D FLOOR |
| IRS990/USAddress/CityNm | 0 | TORRANCE |
| IRS990/USAddress/StateAbbreviationCd | 0 | CA |
| IRS990/USAddress/ZIPCd | 0 | 90502 |
| IRS990/VotingMembersGoverningBodyCnt | 0 | 3 |
| IRS990/VotingMembersIndependentCnt | 0 | 3 |
| IRS990/WebsiteAddressTxt | 0 | WWW.CLOCKFOUNDATION.ORG |
| IRS990/WhistleblowerPolicyInd | 0 | true |
| ReturnHeader/BuildTS | 0 | 2022-09-23 18:48:47Z |
| ReturnHeader/BusinessOfficerGrp/PersonNm | 0 | ROBERT BROOKE |
| ReturnHeader/BusinessOfficerGrp/PersonTitleTxt | 0 | EXECUTIVE DIRECTOR |
| ReturnHeader/BusinessOfficerGrp/PhoneNum | 0 | 8189213980 |
| ReturnHeader/BusinessOfficerGrp/SignatureDt | 0 | 2022-11-29 |
| ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt | 0 | EPIGENETIC CLOCK DEVELOPMENT |
| ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt | 0 | FOUNDATION |
| ReturnHeader/Filer/BusinessNameControlTxt | 0 | EPIG |
| ReturnHeader/Filer/EIN | 0 | 851457272 |
| ReturnHeader/Filer/USAddress/AddressLine1Txt | 0 | 1124 W CARSON ST BLDG 3RD |
| ReturnHeader/Filer/USAddress/CityNm | 0 | TORRANCE |
| ReturnHeader/Filer/USAddress/StateAbbreviationCd | 0 | CA |
| ReturnHeader/Filer/USAddress/ZIPCd | 0 | 90502 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmEIN | 0 | 454205322 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt | 0 | HW LLP |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt | 0 | 16501 VENTURA BLVD STE 400 |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm | 0 | ENCINO |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd | 0 | CA |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd | 0 | 91436 |
| ReturnHeader/PreparerPersonGrp/PhoneNum | 0 | 8189213980 |
| ReturnHeader/PreparerPersonGrp/PreparationDt | 0 | 2022-12-01 |
| ReturnHeader/PreparerPersonGrp/PreparerPersonNm | 0 | LOUIS N HAMEL CPA |
| ReturnHeader/ReturnTs | 0 | 2022-12-05T15:35:35-05:00 |
| ReturnHeader/ReturnTypeCd | 0 | 990 |
| ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm | 0 | ROBERT |
| ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm | 0 | BROOKE |
| ReturnHeader/TaxPeriodBeginDt | 0 | 2021-01-01 |
| ReturnHeader/TaxPeriodEndDt | 0 | 2021-12-31 |
| ReturnHeader/TaxYr | 0 | 2021 |
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2021 • Form 990Detailed filing. Detailed filing data is available for this year.